Ser44
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser44  -  ROMK (human)

Site Information
RQRARLVsKDGRCNI   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 449605

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 1 , 2 , 3 ) , western blotting ( 3 )
Relevant cell line - cell type - tissue:
oocyte ( 1 , 2 , 3 )

Downstream Regulation
Effects of modification on ROMK:
activity, inhibited ( 1 ) , protein processing ( 3 )

References 

1

Lee CH, et al. (2008) d-Amphetamine inhibits inwardly rectifying potassium channels in Xenopus oocytes expression system. Neurotoxicology 29, 638-46
18571730   Curated Info

2

Lee CH, Lee CY, Tsai TS, Liou HH (2008) PKA-mediated phosphorylation is a novel mechanism for levetiracetam, an antiepileptic drug, activating ROMK1 channels. Biochem Pharmacol 76, 225-35
18547545   Curated Info

3

O'Connell AD, et al. (2005) Phosphorylation-regulated endoplasmic reticulum retention signal in the renal outer-medullary K+ channel (ROMK). Proc Natl Acad Sci U S A 102, 9954-9
15987778   Curated Info